Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$0.12 | -$0.11 | -$0.12 |
| Q2 2026 | 1 | -$0.11 | -$0.10 | -$0.11 |
| Q3 2026 | 1 | -$0.22 | -$0.22 | -$0.22 |
| Q4 2026 | 1 | $0.23 | $0.24 | $0.24 |
| Q1 2027 | 1 | -$0.01 | -$0.01 | -$0.01 |
| Q2 2027 | 1 | -$0.03 | -$0.03 | -$0.03 |
| Q3 2027 | 1 | -$0.02 | -$0.02 | -$0.02 |
| Q4 2027 | 1 | $0.41 | $0.41 | $0.41 |
Biofrontera Inc last posted its earnings results on Thursday, August 13th, 2026. The company reported $-0.05 earnings per share for the quarter, topping analysts' consensus estimates of $-0.105 by $0.055. The company had revenue of 12.00 M for the quarter and had revenue of 41.71 M for the year. Biofrontera Inc has generated $-1 earnings per share over the last year ($-0.9 diluted earnings per share) and currently has a price-to-earnings ratio of -2.47. Biofrontera Inc has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/13/2026 | Q2 2026 | -$0.11 | -$0.05 | 0.06 | $9.50 M | $12.00 M |
| 05/14/2026 | Q1 2026 | -$0.18 | -$0.41 | -0.23 | $10.25 M | $10.08 M |
| 03/19/2026 | Q4 2025 | $0.20 | $0.48 | 0.29 | $16.15 M | $17.10 M |
| 11/12/2025 | Q3 2025 | -$0.60 | -$0.62 | -0.02 | $7.00 M | $6.99 M |
| 08/13/2025 | Q2 2025 | -$0.45 | -$0.57 | -0.12 | $8.30 M | $9.03 M |
| 05/15/2025 | Q1 2025 | -$0.22 | -$0.76 | -0.55 | $10.55 M | $8.59 M |
| 03/20/2025 | Q4 2024 | N/A | -$0.19 | N/A | $14.55 M | $12.56 M |
| 11/13/2024 | Q3 2024 | N/A | -$0.98 | N/A | $10.00 M | $9.01 M |
| 08/14/2024 | Q2 2024 | N/A | -$0.05 | N/A | $8.21 M | $7.84 M |
| 05/15/2024 | Q1 2024 | -$1.17 | -$2.88 | -1.71 | $10.86 M | $7.90 M |
| 03/15/2024 | Q4 2023 | N/A | $1.65 | N/A | $11.52 M | $10.60 M |
| 11/09/2023 | Q3 2023 | -$3.78 | -$4.64 | -0.86 | $8.43 M | $8.90 M |
| 08/11/2023 | Q2 2023 | -$5.14 | -$7.23 | -2.09 | $6.20 M | $5.85 M |
| 05/12/2023 | Q1 2023 | -$3.90 | -$5.60 | -1.7 | $9.15 M | $8.73 M |
| 03/13/2023 | Q4 2022 | N/A | -$2.09 | N/A | $10.35 M | $10.14 M |
| 11/14/2022 | Q3 2022 | -$0.32 | -$2.26 | -1.94 | $4.30 M | $4.32 M |
| 08/12/2022 | Q2 2022 | -$6.20 | -$0.90 | 5.3 | $4.55 M | $4.46 M |
| 05/13/2022 | Q1 2022 | -$3.00 | $6.50 | 9.5 | $9.83 M | $9.75 M |
| 04/08/2022 | Q4 2021 | N/A | -$25.90 | N/A | $9.24 M | $9.17 M |
| 11/30/2021 | Q3 2021 | -$11.60 | -$40.03 | -28.43 | $4.86 M | $4.33 M |
In the previous quarter, Biofrontera Inc (:BFRI) reported $-0.05 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.105 by $0.055.
The conference call for Biofrontera Inc's latest earnings report can be listened to online.
The conference call transcript for Biofrontera Inc's latest earnings report can be read online.
Biofrontera Inc (:BFRI) has a recorded annual revenue of $41.71 M.
Biofrontera Inc (:BFRI) has a recorded net income of $-10,536,000.Biofrontera Inc has generated $-1.04 earnings per share over the last four quarters.
Biofrontera Inc (:BFRI) has a price-to-earnings ratio of -2.47 and price/earnings-to-growth ratio is -0.01.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED